Modern Healthcare Technology Holdings (STU:M3L) Short-Term Debt: €0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Modern Healthcare Technology Holdings Short-Term Debt?

Modern Healthcare Technology Holdings STU:M3L Short-Term Debt is €0.00 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Modern Healthcare Technology Holdings's Short-Term Debt for the quarter that ended in Mar. 2026 was €0.00 Mil.

Modern Healthcare Technology Holdings's quarterly Short-Term Debt declined from Mar. 2025 (€0.04 Mil) to Sep. 2025 (€0.01 Mil) and declined from Sep. 2025 (€0.01 Mil) to Mar. 2026 (€0.00 Mil).

Modern Healthcare Technology Holdings's annual Short-Term Debt declined from Mar. 2024 (€0.07 Mil) to Mar. 2025 (€0.04 Mil) and declined from Mar. 2025 (€0.04 Mil) to Mar. 2026 (€0.00 Mil).

Modern Healthcare Technology Holdings Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Modern Healthcare Technology Holdings Short-Term Debt Related Terms

Modern Healthcare Technology Holdings Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Modern Healthcare Technology Holdings's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modern Healthcare Technology Holdings Short-Term Debt Chart

Modern Healthcare Technology Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.07 0.04 0.00

Modern Healthcare Technology Holdings Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.08 0.04 0.01 0.00
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of €0.00 Mil mean?
Modern Healthcare Technology Holdings (STU:M3L) has a Short-Term Debt of €0.00 Mil as of Mar. 2026.
Is Modern Healthcare Technology Holdings' Short-Term Debt too high?
Modern Healthcare Technology Holdings' current Short-Term Debt is €0.00 Mil.
How does Modern Healthcare Technology Holdings' Short-Term Debt compare to ROL and SCI?
Modern Healthcare Technology Holdings' Short-Term Debt of €0.00 Mil can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Personal Services company?
A good Short-Term Debt depends on the Personal Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Modern Healthcare Technology Holdings's current Short-Term Debt is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Healthcare Technology Holdings stock overvalued right now?
Based on GuruFocus' analysis, Modern Healthcare Technology Holdings (STU:M3L) is currently considered Possible Value Trap. The stock's GF Value™ is €0.01, compared to a current price of €0.01 — trading 40% below its estimated fair value. The current Short-Term Debt is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Modern Healthcare Technology Holdings (STU:M3L), the current Short-Term Debt is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Modern Healthcare Technology Holdings Business Description

Other Exchanges 00919:Hong Kong
Address 9 Kai Cheung Road, Workshops Nos. 66-68, 6th Floor, Sino Industrial Plaza, Kowloon Bay, Kowloon, Hong Kong, HKG
Modern Healthcare Technology Holdings Ltd is an investment holding company. The company's operating segment includes Beauty and wellness services and Skincare and wellness products. The company generates maximum revenue from Beauty and wellness services segment. The Beauty and Wellness Services segment of the company is engaged in the provision of beauty and wellness services which provides a wide range of health and beauty services, covering skin care, slimming, massage, spa, hair care, manicure, hair removal, makeup, joint care, and privacy care. Geographically, the company derives the maximum of its revenue from Hong Kong and has a presence in Singapore; China, and Australia.